This project is focused on physiologically critical functions of NF-kappaB proteins and their regulators in the context of specific biologic reactions in vivo. Regulators of interest include the classical inhibitory IkappaB proteins, the non-inhibitory IkappaB family protein Bcl-3, as well as proximal components of the numerous signaling pathways that lead to to activation of NF-kappaB. Research is based on the discovery of specific defects (especially of the immune system) in mice rendered deficient for various NF- kappaB proteins or their regulators. The ultimate goal is to identify critical molecular targets of the NF-kappaB factors in specific immune responses/diseases and to identify the essential signaling pathways that activate the factors in these situations. Previously we generated mice deficient in both NF-kappaB1 and NF-kappaB2. These double knockout mice are completely blocked in the development of mature osteoclasts and of mature B cells. We have determined in adoptive transfer experiments that the blocks in generation of mature B cells and mature osteoclasts are intrinsic to these cell lineages. B cell development in double knockout mice is blocked during an early transitional stage in spleen, resulting in a complete absence of recirculating mature B cells. The mutant B cells are intrinsically more apoptotic than their wild-type counterparts. We now show that introduction of Bcl-2 into these double-deficient B cells, either via a transgene or via lentivirus-mediated transduction of bone marrow cells rescues the developmental block and allows for further progression of B cells. However, these Bcl-2-rescued, mutant B cells still fail to fully mature phenotypically and functionally. Neither constitutive nor antigen-stimulated antibody production is restored. Thus NF-kappaB1,2 are required for survival and functional maturation of B cells. We have shown previously that one of the signals responsible for activation of NF-kappaB in early transitional B cells comes from the BAFF receptor, a member of the TNF receptor family. The ligand BAFF induces processing of NF-kappaB2 p100 to p52, which activates nuclear translocation of RelB/p52. NF-kappaB2 processing is also important in stromal cells of lymphoid organs in response the lymphotoxin beta receptor stimulation, where it contributes to development of follicular dendritic cell network, B cell follicles, germinal centers and lymph node formation. Mice deficient in the IkappaB-like regulator Bcl-3 have milder, but similar phenotypes. However, we now show that Bcl-3, NF-kappaB2 double knockouts have unexpected additional phenotypes, including a severe multiorgan inflammation. This indicates unexpected redundant activities of these two proteins. Finally we have discovered that lack of NF-kappaB2 also prevents obesity-induced insulin resistance in standard assays, a phenomenon that are presently characterizing in detail.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000722-10
Application #
6986325
Study Section
(LIR)
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
2004
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Wang, Tao; Tian, Linhua; Haino, Makoto et al. (2007) Improved antibacterial host defense and altered peripheral granulocyte homeostasis in mice lacking the adhesion class G protein receptor CD97. Infect Immun 75:1144-53
Zhang, Xiaoren; Wang, Hongshan; Claudio, Estefania et al. (2007) A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance. Immunity 27:438-52
Pascal, Veronique; Nathan, Neera R; Claudio, Estefania et al. (2007) NF-kappa B p50/p65 affects the frequency of Ly49 gene expression by NK cells. J Immunol 179:1751-9
Zhu, Mingzhao; Chin, Robert K; Christiansen, Peter A et al. (2006) NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest 116:2964-71
Claudio, E; Brown, K; Siebenlist, U (2006) NF-kappaB guides the survival and differentiation of developing lymphocytes. Cell Death Differ 13:697-701
Siebenlist, Ulrich; Brown, Keith; Claudio, Estefania (2005) Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 5:435-45
Corn, Radiah A; Hunter, Chris; Liou, Hsiou-Chi et al. (2005) Opposing roles for RelB and Bcl-3 in regulation of T-box expressed in T cells, GATA-3, and Th effector differentiation. J Immunol 175:2102-10
Xing, Lianping; Carlson, Louise; Story, Beryl et al. (2003) Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. J Bone Miner Res 18:260-9
Muller, Jurgen R; Siebenlist, Ulrich (2003) Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem 278:12006-12
Chariot, Alain; Meuwis, Marie-Alice; Bonif, Marianne et al. (2003) NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets. Curr Med Chem 10:593-602

Showing the most recent 10 out of 22 publications